Semax | Selank Blend
A combination product pairing two Russian-developed neuropeptides studied for complementary cognitive enhancement and anxiety reduction effects.
Molecular Structure
Amino Acid Sequence
Molecular Formula
Molecular Weight
Half-Life
CAS Number
What is Semax | Selank Blend?
The Semax | Selank Blend is a combination product containing two distinct Russian-developed neuropeptides commonly used together for their complementary effects on cognitive function and anxiety. Both compounds were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and have been approved as prescription medications in Russia, where they have decades of clinical use. Neither peptide is approved by the FDA, EMA, or other major Western regulators. The two peptides are not chemically combined into a single molecule but rather sold together for convenience, with the rationale that their effects are complementary.
The combination is notable in research because of the unusual profile of effects each peptide produces. Semax is a synthetic heptapeptide based on the 4-10 fragment of adrenocorticotropic hormone (ACTH), studied for cognitive enhancement and neuroprotective effects without affecting adrenal function. Selank is a synthetic heptapeptide based on the structure of tuftsin (a natural immunomodulatory tetrapeptide), studied for anxiolytic effects without the typical benzodiazepine side effects of sedation, dependence, or cognitive impairment. The pairing rationale is that Semax provides cognitive enhancement while Selank reduces anxiety, theoretically avoiding the cognitive impairment trade-off seen with conventional anxiolytic compounds.
Mechanism of action
The Semax | Selank Blend’s mechanisms of action have been investigated across multiple pathways:
- Semax — BDNF upregulation: Semax has been shown to increase brain-derived neurotrophic factor expression in brain tissue, supporting neuronal survival, synaptic plasticity, and cognitive function.
- Semax — Dopaminergic and serotonergic effects: The peptide influences dopamine and serotonin neurotransmission, with research demonstrating neuroprotective effects in models of ischemic injury and effects on attention and motivation.
- Semax — Stability via C-terminal extension: The Pro-Gly-Pro extension added to the native ACTH (4-10) fragment confers resistance to enzymatic degradation while preserving biological activity.
- Selank — GABAergic system modulation: Selank produces anxiolytic effects through effects on GABA signaling, with research showing anxiolytic potency comparable to benzodiazepines without sedative or dependence-producing effects.
- Selank — Immunomodulation via tuftsin pathway: As a tuftsin analog, Selank retains immune-modulating effects of the parent tetrapeptide, with documented effects on cytokine production and immune cell function.
These pathways are characterized in both preclinical models and Russian clinical research.
Research applications
The Semax | Selank Blend has been investigated across several research domains, with the most active areas including:
- Combined cognitive and anxiety research: The pairing is intended to provide cognitive enhancement through Semax alongside anxiety reduction through Selank, with research interest in whether the combination produces synergistic effects compared to either peptide alone.
- Semax stroke recovery research: Semax has been most extensively studied in stroke recovery research, where it has shown clinical efficacy in Russian trials examining neurological recovery, neuroprotection, and functional outcomes.
- Selank anxiety research: Selank has been studied for anxiolytic effects in research involving generalized anxiety, where it has demonstrated effects comparable to benzodiazepines without typical sedative or dependence-producing effects.
- Neuroprotection research: Both peptides have been examined in models of neural injury, oxidative stress, and neurodegeneration, with research suggesting complementary protective effects through different molecular pathways.
- Comparative Russian peptide research: The combination is studied within the broader Russian nootropic peptide research tradition that includes other compounds developed in the same scientific framework.
This compound is intended for laboratory research use only. It has not been approved for human therapeutic use by any regulatory agency.
Storage & reconstitution
In lyophilized form, both Semax and Selank tolerate ambient temperatures during shipping but should be stored long-term at -20°C, protected from light. Properly stored lyophilized peptides remain stable for 24 months or longer.
Once reconstituted with bacteriostatic water for injection, solutions should be stored refrigerated at 2-8°C and used within 28 days. In approved Russian clinical use, both peptides are administered as intranasal solutions; research applications may use different administration routes with corresponding formulation considerations. Avoid repeated freeze-thaw cycles, which can degrade peptide structure and reduce activity.
Visual inspection should be performed before each use. The reconstituted solutions should be clear and colorless. Reject any solution that appears cloudy, discolored, or contains visible particulate matter.
For step-by-step reconstitution calculations, see our reconstitution calculator.
For laboratory research use only. The compound described on this page is intended exclusively for in vitro research and laboratory experimentation by qualified researchers and is not for human or veterinary use. It is not a drug, food, dietary supplement, or cosmetic, and has not been approved by the FDA, Health Canada, EMA, or any other regulatory authority for the diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition. The information provided on this page is for educational and reference purposes only and does not constitute medical advice. By accessing this content you confirm that you are a qualified researcher purchasing for legitimate laboratory purposes.